Fleming T P, Watson M A
Department of Surgery/Box 8109, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
Ann N Y Acad Sci. 2000;923:78-89. doi: 10.1111/j.1749-6632.2000.tb05521.x.
The mammaglobin gene encodes a 10-kDa glycoprotein that is distantly related to a family of proteins that includes rat estramustine binding protein (EMBP)/prostatein and human Clara cell 10-kDa protein (CC10)/uteroglobin. Among normal adult tissues, mammaglobin mRNA expression has been detected only in the mammary gland. As an initial step to determine mammaglobin's clinical utility as a breast tumor marker, we evaluated the frequency and specificity with which mammaglobin expression could be detected in primary breast tumors, metastatic breast tumors, and breast tumor cells present in the peripheral circulation. Approximately 80% of all primary and metastatic breast tumors examined were strongly immunopositive for mammaglobin protein, and staining was independent of tumor grade. Among peripheral stem cell collections from breast cancer patients, mammaglobin mRNA could be detected in 60% of cases. Recent work has identified the secreted mammaglobin protein in the sera of some breast cancer patients using both Western blot and ELISA. This study demonstrates that the detection of mammaglobin protein and mRNA in clinical samples may be a useful marker for primary, metastatic, and occult breast cancer.
乳腺珠蛋白基因编码一种10 kDa的糖蛋白,它与一个蛋白质家族有较远的亲缘关系,该家族包括大鼠雌莫司汀结合蛋白(EMBP)/前列腺素和人类克拉拉细胞10 kDa蛋白(CC10)/子宫珠蛋白。在正常成人组织中,仅在乳腺中检测到乳腺珠蛋白mRNA表达。作为确定乳腺珠蛋白作为乳腺肿瘤标志物临床应用价值的第一步,我们评估了在原发性乳腺肿瘤、转移性乳腺肿瘤和外周循环中存在的乳腺肿瘤细胞中检测乳腺珠蛋白表达的频率和特异性。在所检查的所有原发性和转移性乳腺肿瘤中,约80%对乳腺珠蛋白蛋白呈强免疫阳性,且染色与肿瘤分级无关。在乳腺癌患者的外周干细胞采集中,60%的病例可检测到乳腺珠蛋白mRNA。最近的研究工作通过蛋白质印迹法和酶联免疫吸附测定法在一些乳腺癌患者的血清中鉴定出了分泌型乳腺珠蛋白蛋白。这项研究表明,在临床样本中检测乳腺珠蛋白蛋白和mRNA可能是原发性、转移性和隐匿性乳腺癌的有用标志物。